ALLERGAN FDA Approval NDA 020655

NDA 020655

ALLERGAN

FDA Drug Application

Application #020655

Documents

Letter2002-04-05
Label2003-12-01
Label2002-04-05
Letter2003-11-26
Letter2005-05-20
Label2005-05-20
Review2004-05-27
Label2017-11-02
Letter2020-03-31
Label2020-03-31

Application Sponsors

NDA 020655ALLERGAN

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001FILM, EXTENDED RELEASE;TRANSDERMAL0.05MG/24HR0ALORAESTRADIOL
002FILM, EXTENDED RELEASE;TRANSDERMAL0.075MG/24HR0ALORAESTRADIOL
003FILM, EXTENDED RELEASE;TRANSDERMAL0.1MG/24HR0ALORAESTRADIOL
004FILM, EXTENDED RELEASE;TRANSDERMAL0.025MG/24HR0ALORAESTRADIOL

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1996-12-20STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1998-04-22STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-11-24STANDARD
LABELING; LabelingSUPPL4AP1999-06-04STANDARD
LABELING; LabelingSUPPL5AP2000-04-14STANDARD
LABELING; LabelingSUPPL6AP2003-11-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-10-02STANDARD
LABELING; LabelingSUPPL8AP2002-04-05STANDARD
LABELING; LabelingSUPPL11AP2005-05-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2013-08-30STANDARD
LABELING; LabelingSUPPL19AP2020-03-30STANDARD
LABELING; LabelingSUPPL20AP2017-11-01STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL7Null0
SUPPL17Null0
SUPPL19Null7
SUPPL20Null15

TE Codes

001PrescriptionBX
002PrescriptionBX
003PrescriptionBX
004PrescriptionBX

CDER Filings

ALLERGAN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20655
            [companyName] => ALLERGAN
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALORA","activeIngredients":"ESTRADIOL","strength":"0.05MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ALORA","activeIngredients":"ESTRADIOL","strength":"0.075MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ALORA","activeIngredients":"ESTRADIOL","strength":"0.1MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ALORA","activeIngredients":"ESTRADIOL","strength":"0.025MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE;TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"03\/30\/2020","submission":"SUPPL-19","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/020655Orig1s019lbl.pdf\"}]","notes":""},{"actionDate":"11\/01\/2017","submission":"SUPPL-20","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020655s020lbl.pdf\"}]","notes":""},{"actionDate":"05\/19\/2005","submission":"SUPPL-11","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/020655s011lbl.pdf\"}]","notes":""},{"actionDate":"11\/18\/2003","submission":"SUPPL-6","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20655slr006_alora_lbl.pdf\"}]","notes":""},{"actionDate":"04\/05\/2002","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/20655s8lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ALORA","submission":"ESTRADIOL","actionType":"0.05MG\/24HR","submissionClassification":"FILM, EXTENDED RELEASE;TRANSDERMAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ALORA","submission":"ESTRADIOL","actionType":"0.075MG\/24HR","submissionClassification":"FILM, EXTENDED RELEASE;TRANSDERMAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ALORA","submission":"ESTRADIOL","actionType":"0.1MG\/24HR","submissionClassification":"FILM, EXTENDED RELEASE;TRANSDERMAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ALORA","submission":"ESTRADIOL","actionType":"0.025MG\/24HR","submissionClassification":"FILM, EXTENDED RELEASE;TRANSDERMAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2020-03-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.